Meurette J, Depadt G, Meynadier J
Eur J Surg Oncol. 1985 Sep;11(3):295-8.
This is a prospective study conducted in order to evaluate totally implanted venous access systems. The report concerning 42 patients is presented. The follow-up is 5 to 17 months (median 9 months). A variety of antineoplastic agents were administered through the device. Complications rarely occur and after utilization all patients are still treated in this way. Physician-, nurse- and patient-acceptance were excellent and this system appears to improve the quality of life style of cancer patients.
这是一项为评估全植入式静脉通路系统而进行的前瞻性研究。本文报告了42例患者的情况。随访时间为5至17个月（中位数为9个月）。通过该装置给予了多种抗肿瘤药物。并发症很少发生，在使用后所有患者仍以这种方式接受治疗。医生、护士和患者的接受度都很高，并且该系统似乎改善了癌症患者的生活质量。
